News

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.
HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.
In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...
HIV vaccines have been in development for decades, but a long-lasting one has yet to be successful. The mRNA technology offers new opportunities because mRNA produces a more potent antibody ...
HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...
We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...
The NIH announced three new trials for an HIV vaccine based on mRNA technology. ABC 10News Reporter Jared Aarons takes an In-Depth look at the role San Diego's Scripps Research played in ...
A Phase I trial showed an HIV vaccine was 97 percent effective. Now Moderna's mRNA tech could help it get to market faster.
Functionally, Moderna's HIV vaccine works just like the company's widely-used, extremely effective mRNA COVID-19 vaccine, which teaches the body how to build up an immune response by producing ...